Page URL: https://www.bionews.org.uk/page_93155

World cup winning South African rugby player to receive stem cell therapy

30 August 2011
Appeared in BioNews 622

A South African rugby player is believed to be the first in his country to receive an experimental stem cell therapy to treat a serious neurological disease.

Joost Van der Westhuizen, 40, was recently diagnosed with a form of motor neurone disease. At first, he thought the problems in his right arm were related to injuries acquired over his 17-year playing career. But as the problems spread to his right leg, he realised it was much more serious.

The treatment Van der Westhuizen is reportedly receiving involves extracting mesenchymal stem cells (MSCs) from fat cells taken from his abdomen which are then injected directly into the weakened muscle. It is hoped the MSCs, which have the ability to become bone, cartilage and neurons, will migrate to the damaged tissue and attempt to repair it. Since they are derived from the patient, there is no risk of rejection.

Van der Westhuizen's neurologist, Dr Jody Pearl, said she remained cautiously optimistic as the method had shown good results in cases abroad. 'This therapy is the most promising treatment we have to date in any kind of degenerative condition', she said.

The former Rugby World Cup winning Springbok was diagnosed with amyotrophic lateral sclerosis (ALS), a condition where nerve cells in the spinal cord and brain, responsible for controlling movements, deteriorate and die. The muscles that control walking, talking, breathing and swallowing become weak and non-functional, resulting in paralysis and death. There is currently no cure for the 350,000 people worldwide with ALS, and the mortality rate is 80 percent within five years.

The treatment, developed by UK neuroscientist Dr Steve Ray, is not available to the general public, and the cost involved was not disclosed.

Van der Westhuizen is not the first sports star to receive stem cell therapy using MSCs. Bartolo Colón, a pitcher for the New York Yankees baseball team, received an injection of MSCs taken from his bone marrow and fatty tissue to repair a damaged elbow and shoulder.

Colón, once sidelined after tearing the rotator cuff in his pitching arm, has since recovered from his injury and is again playing in Major League Baseball (MLB) games. MLB is reportedly investigating whether the treatment could qualify as a performance-enhancing drug.

SOURCES & REFERENCES
Joost holds out hope
IOL News |  25 August 2011
Joost undergoes experimental treatment: Report
Times Live |  25 August 2011
Rugby world cup winner has stem cell therapy to tackle killer disease
Sydney Morning Herald |  26 August 2011
Rugby World Cup winner Joost van der Westhuizen undergoes stem cell therapy
Telegraph |  25 August 2011
Stem cell therapy wasn't unfair help for baseball star
New Scientist |  8 June 2011
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
26 March 2012 - by Luciana Strait 
Consider a future world where pharmaceutical and genetic enhancements are the norm for sporting champions, where today's world records are smashed into oblivion...
24 October 2011 - by Luciana Strait 
An unnamed Premier League football club has had DNA tests carried out on its players to determine which of them may be susceptible to injury. The tests were carried out by leading molecular geneticist and assistant professor at Yale University School of Medicine Dr Marios Kambouris, who was told neither the name of the club nor the identities of the players...
17 October 2011 - by Jessica Ware 
A US doctor accused of implanting stem cells into chronically ill patients pleaded not guilty at a court hearing on Thursday 13 October. Dr Ralph Conti, of Henderson, Nevada, has been accused of transplanting stem cells harvested from placental tissue into patients, at the direction of Alfred Sapse, who was falsely claiming to be a doctor....
12 September 2011 - by Rosie Beauchamp 
An Australian company has announced it has received regulatory approval from the European Medicines Agency (EMA) to begin phase II trials for its cardiovascular stem cell treatment, Revascor....
14 March 2011 - by Rosemary Paxman 
Stem cell research is one of the most exciting areas of 21st century science. If offers potentially revolutionary ways to repair diseased and damaged body tissues by replacing them with healthy cells. But how close are we to bringing such therapies to the clinic?...
29 November 2010 - by Dr Rachael Panizzo 
A British man has become the first patient in the world to receive a pioneering stem cell therapy to repair brain damage caused by stroke....
25 October 2010 - by Dr Karen Devine 
This colourful, illustrated guide to stem cells is the perfect companion for any student wishing to gain a greater understanding of stem cell research, use and ethical debates...
15 February 2010 - by Dr Sophie Pryor 
Researchers have expressed concern about athlete's use of genetic tools in the 'next generation' of illegal doping, and have stressed the importance of developing reliable new detection tests to stop them. Writing in the journal Science, Theodore Friedmann and colleagues at the University of California warn that 'the time is right to look at how advances in genetics are affecting sport'. The authors highlight the dangers of using imperfect and 'highly risky' genetic techniques, which may have...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.